Please enable JavaScript to continue using this application.

Compare $IPSC vs $ZSQR | Chartloom

Compare

$IPSC vs $ZSQR

Century Therapeutics Inc · Z Squared Inc (Delaware)

IPSC

Century Therapeutics Inc

ZSQR

Z Squared Inc (Delaware)

Compare $IPSC vs $ZSQR

Comparing Century Therapeutics Inc and Z Squared Inc (Delaware)

IPSCCentury Therapeutics Inc

ZSQRZ Squared Inc (Delaware)

IPSCCentury Therapeutics Inc

Market cap

$265M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

47.8%

52W performance

151.9%

FCF yield

-33.3%

ZSQRZ Squared Inc (Delaware)

Market cap

$298M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

961.0%

YTD performance

-62.8%

52W performance

-62.8%

FCF yield

-1.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IPSC

ZSQR

Detailed metrics comparison

IPSC

Century Therapeutics Inc

ZSQR

Z Squared Inc (Delaware)

Market Cap

IPSC$265M

ZSQR$298M

Enterprise Value

IPSC$215M

ZSQR$283M

Price

IPSC$1.47

ZSQR$5.66

P/E Ratio

IPSCN/A

ZSQRN/A

P/S Ratio

IPSC2.41x

ZSQR106.71x

EV/Sales

IPSC1.98x

ZSQR101.17x

EV/EBITDA

IPSC0.00x

ZSQR0.00x

P/B Ratio

IPSC1.19x

ZSQR1.36x

P/FCF Ratio

IPSCN/A

ZSQRN/A

EV/FCF

IPSC-2.44x

ZSQR-69.99x

PEG Ratio

IPSCN/A

ZSQRN/A

Forward P/E (NTM)

IPSCN/A

ZSQRN/A

Forward P/S (NTM)

IPSCN/A

ZSQRN/A

Revenue (TTM)

IPSC$0

ZSQR$3M

Revenue Growth (YoY)

IPSC-100.0%

ZSQR961.0%

Forward Rev Growth

IPSC385.7%

ZSQR0.0%

Gross Margin (TTM)

IPSC0.0%

ZSQR-24.6%

Operating Margin (TTM)

IPSC0.0%

ZSQR0.0%

EBITDA Margin (TTM)

IPSC0.0%

ZSQR-712.5%

Net Margin (TTM)

IPSC0.0%

ZSQR-785.1%

FCF Margin (TTM)

IPSCN/A

ZSQR-144.6%

Net Income (TTM)

IPSC$-110M

ZSQR$-22M

FCF (TTM)

IPSC$-88M

ZSQR$-4M

EPS (TTM)

IPSC-$0.53

ZSQR-$0.44

ROE (TTM)

IPSC-5276.0%

ZSQR-5059.0%

ROA (TTM)

IPSC-4059.0%

ZSQR-4757.0%

ROIC (TTM)

IPSC-5276.0%

ZSQR-5038.0%

Cash

IPSC$50M

ZSQR$15M

Debt

IPSC$0

ZSQR$0

Net Cash/Debt

IPSC$50M

ZSQR$15M

Current Ratio (TTM)

IPSC8.28x

ZSQR7.66x

Quick Ratio (TTM)

IPSC7.94x

ZSQR7.64x

Debt/Equity (TTM)

IPSC0.00x

ZSQR0.02x

Debt/Assets (TTM)

IPSC0.0%

ZSQR0.0%

Interest Coverage (TTM)

IPSCN/A

ZSQRN/A

Net Debt/EBITDA (TTM)

IPSC0.00x

ZSQR0.00x

Beta

IPSC1.74

ZSQRN/A

52W Performance

IPSC151.9%

ZSQR-62.8%

YTD Performance

IPSC47.8%

ZSQR-62.8%

% from 52W High

IPSC-51.6%

ZSQR-69.9%

% from 52W Low

IPSC237.9%

ZSQR168.2%

Asset Turnover (TTM)

IPSC0.31x

ZSQR0.06x

FCF Yield (TTM)

IPSC-33.3%

ZSQR-1.4%

Earnings Yield (TTM)

IPSC-41.4%

ZSQR-7.4%

Dividend Yield (TTM)

IPSCN/A

ZSQRN/A

Rule of 40

IPSC-100.0

ZSQR816.4

EV/GP/RG

IPSCN/A

ZSQRN/A

Ticker research

View IPSC research View ZSQR research

Metric	IPSC Century Therapeutics Inc	ZSQR Z Squared Inc (Delaware)
Market & Valuation
Market Cap	$265M	$298M
Enterprise Value	$215M	$283M
Price	$1.47	$5.66
P/E Ratio	N/A	N/A
P/S Ratio	2.41x	106.71x
EV/Sales	1.98x	101.17x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	1.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.44x	-69.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	-100.0%	961.0%
Forward Rev Growth	385.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-24.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-712.5%
Net Margin (TTM)	0.0%	-785.1%
FCF Margin (TTM)	N/A	-144.6%
Net Income (TTM)	$-110M	$-22M
FCF (TTM)	$-88M	$-4M
EPS (TTM)	-$0.53	-$0.44
ROE (TTM)	-5276.0%	-5059.0%
ROA (TTM)	-4059.0%	-4757.0%
ROIC (TTM)	-5276.0%	-5038.0%
Financial Health
Cash	$50M	$15M
Debt	$0	$0
Net Cash/Debt	$50M	$15M
Current Ratio (TTM)	8.28x	7.66x
Quick Ratio (TTM)	7.94x	7.64x
Debt/Equity (TTM)	0.00x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	N/A
52W Performance	151.9%	-62.8%
YTD Performance	47.8%	-62.8%
% from 52W High	-51.6%	-69.9%
% from 52W Low	237.9%	168.2%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.06x
FCF Yield (TTM)	-33.3%	-1.4%
Earnings Yield (TTM)	-41.4%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	816.4
EV/GP/RG	N/A	N/A
Ticker research	View IPSC research	View ZSQR research

Valuation

P/S Ratio

IPSC

2.41x

ZSQR

106.71x

EV/FCF

ZSQR

-69.99x

IPSC

-2.44x

Growth & revenue

Revenue Growth TTM

ZSQR

961.0%

IPSC

-100.0%

Forward Revenue Growth

IPSC

385.7%

ZSQR

0.0%

Profitability & performance

Gross Margin

IPSC

0.0%

ZSQR

-24.6%

ROE

ZSQR

-5059.0%

IPSC

-5276.0%

FCF Yield %

ZSQR

-1.4%

IPSC

-33.3%

52-Week Performance

IPSC

151.9%

ZSQR

-62.8%

Detailed metrics comparison

IPSC

Century Therapeutics Inc

ZSQR

Z Squared Inc (Delaware)

Market Cap

IPSC$265M

ZSQR$298M

Enterprise Value

IPSC$215M

ZSQR$283M

Price

IPSC$1.47

ZSQR$5.66

P/E Ratio

IPSCN/A

ZSQRN/A

P/S Ratio

IPSC2.41x

ZSQR106.71x

EV/Sales

IPSC1.98x

ZSQR101.17x

EV/EBITDA

IPSC0.00x

ZSQR0.00x

P/B Ratio

IPSC1.19x

ZSQR1.36x

P/FCF Ratio

IPSCN/A

ZSQRN/A

EV/FCF

IPSC-2.44x

ZSQR-69.99x

PEG Ratio

IPSCN/A

ZSQRN/A

Forward P/E (NTM)

IPSCN/A

ZSQRN/A

Forward P/S (NTM)

IPSCN/A

ZSQRN/A

Revenue (TTM)

IPSC$0

ZSQR$3M

Revenue Growth (YoY)

IPSC-100.0%

ZSQR961.0%

Forward Rev Growth

IPSC385.7%

ZSQR0.0%

Gross Margin (TTM)

IPSC0.0%

ZSQR-24.6%

Operating Margin (TTM)

IPSC0.0%

ZSQR0.0%

EBITDA Margin (TTM)

IPSC0.0%

ZSQR-712.5%

Net Margin (TTM)

IPSC0.0%

ZSQR-785.1%

FCF Margin (TTM)

IPSCN/A

ZSQR-144.6%

Net Income (TTM)

IPSC$-110M

ZSQR$-22M

FCF (TTM)

IPSC$-88M

ZSQR$-4M

EPS (TTM)

IPSC-$0.53

ZSQR-$0.44

ROE (TTM)

IPSC-5276.0%

ZSQR-5059.0%

ROA (TTM)

IPSC-4059.0%

ZSQR-4757.0%

ROIC (TTM)

IPSC-5276.0%

ZSQR-5038.0%

Cash

IPSC$50M

ZSQR$15M

Debt

IPSC$0

ZSQR$0

Net Cash/Debt

IPSC$50M

ZSQR$15M

Current Ratio (TTM)

IPSC8.28x

ZSQR7.66x

Quick Ratio (TTM)

IPSC7.94x

ZSQR7.64x

Debt/Equity (TTM)

IPSC0.00x

ZSQR0.02x

Debt/Assets (TTM)

IPSC0.0%

ZSQR0.0%

Interest Coverage (TTM)

IPSCN/A

ZSQRN/A

Net Debt/EBITDA (TTM)

IPSC0.00x

ZSQR0.00x

Beta

IPSC1.74

ZSQRN/A

52W Performance

IPSC151.9%

ZSQR-62.8%

YTD Performance

IPSC47.8%

ZSQR-62.8%

% from 52W High

IPSC-51.6%

ZSQR-69.9%

% from 52W Low

IPSC237.9%

ZSQR168.2%

Asset Turnover (TTM)

IPSC0.31x

ZSQR0.06x

FCF Yield (TTM)

IPSC-33.3%

ZSQR-1.4%

Earnings Yield (TTM)

IPSC-41.4%

ZSQR-7.4%

Dividend Yield (TTM)

IPSCN/A

ZSQRN/A

Rule of 40

IPSC-100.0

ZSQR816.4

EV/GP/RG

IPSCN/A

ZSQRN/A

Ticker research

View IPSC research View ZSQR research

Metric	IPSC Century Therapeutics Inc	ZSQR Z Squared Inc (Delaware)
Market & Valuation
Market Cap	$265M	$298M
Enterprise Value	$215M	$283M
Price	$1.47	$5.66
P/E Ratio	N/A	N/A
P/S Ratio	2.41x	106.71x
EV/Sales	1.98x	101.17x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	1.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.44x	-69.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	-100.0%	961.0%
Forward Rev Growth	385.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-24.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-712.5%
Net Margin (TTM)	0.0%	-785.1%
FCF Margin (TTM)	N/A	-144.6%
Net Income (TTM)	$-110M	$-22M
FCF (TTM)	$-88M	$-4M
EPS (TTM)	-$0.53	-$0.44
ROE (TTM)	-5276.0%	-5059.0%
ROA (TTM)	-4059.0%	-4757.0%
ROIC (TTM)	-5276.0%	-5038.0%
Financial Health
Cash	$50M	$15M
Debt	$0	$0
Net Cash/Debt	$50M	$15M
Current Ratio (TTM)	8.28x	7.66x
Quick Ratio (TTM)	7.94x	7.64x
Debt/Equity (TTM)	0.00x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	N/A
52W Performance	151.9%	-62.8%
YTD Performance	47.8%	-62.8%
% from 52W High	-51.6%	-69.9%
% from 52W Low	237.9%	168.2%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.06x
FCF Yield (TTM)	-33.3%	-1.4%
Earnings Yield (TTM)	-41.4%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	816.4
EV/GP/RG	N/A	N/A
Ticker research	View IPSC research	View ZSQR research